Manchester United MANU 2025Q3 Earnings Preview Downside Expected Amid EPS Decline

Forward-Looking Analysis
Manchester United is set to release its Q3 2025 earnings report next week, with analysts forecasting a revenue of $162.31 million and an earnings per share (EPS) of -$0.22. The trailing EPS has been noted at -$1.02, with expectations to decrease further next year from ($0.74) to ($0.82) per share. This indicates a continued negative trend in earnings, reflecting ongoing financial challenges. Despite revenue guidance of £650 million to £670 million for fiscal 2025, adjusted EBITDA is expected at the high end of previous forecasts. Institutional investor activity has seen mixed movements, with notable additions and removals of shares from various portfolios. UBS issued a "Buy" rating, showing some optimism from analysts, but overall, the outlook remains cautious due to declining EPS forecasts and mixed institutional sentiment.

Historical Performance Review
In 2025Q2, Manchester United reported revenue of $198.70 million, with a net income of -$27.75 million and an EPS of -$0.16. The gross profit matched the revenue at $198.70 million, indicating the company's inability to convert sales into positive earnings. This continued financial struggle has been characterized by ongoing losses and a negative EPS, underscoring challenges in improving profitability.

Additional News
Recent news around Manchester United highlights significant investor activity, with 50 institutional investors adding shares and 57 decreasing their positions in the latest quarter. INFINITUM ASSET MANAGEMENT, LLC notably increased its holdings by 1209%, while SENVEST MANAGEMENT, LLC, and others have completely exited their positions. The stock faced a slight decline, trading down 0.6% to $14.09, amidst a trading volume of 190,753 shares. The upcoming earnings report is poised to further influence market sentiment, with analysts closely monitoring the company's financial trajectory and investor confidence.

Summary & Outlook
Manchester United's financial health remains precarious, with consistent negative earnings and declining EPS forecasts. Despite revenue guidance and some institutional optimism, the overall outlook appears bearish due to persistent profitability issues. Growth catalysts are limited, and risk factors include continued financial losses and investor sentiment shifts. While some analysts maintain a "Buy" rating, the focus remains on overcoming operational and financial challenges to stabilize and potentially reverse the current trend.